Impel Pharmaceuticals Inc (IMPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMPL | ZTS | TAK | NBIX | UTHR |
| Company | Impel Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0450 | 163.10 | 13.29 | 143.79 | 255.10 |
| High | 0.0500 | 169.99 | 13.31 | 144.09 | 260.34 |
| Low | 0.0212 | 161.38 | 13.21 | 139.63 | 253.93 |
| Last | 0.0400 | 167.23 | 13.27 | 139.83 | 258.13 |
| Change | -0.0150 | +8.73 | +0.08 | -3.20 | +2.99 |
| % Change | -27.27% | +5.51% | +0.61% | -2.24% | +1.17% |
| Volume | 720,000 | 5,323,100 | 1,033,500 | 882,400 | 717,100 |
| 20-Day Average Volume | 2,299,260 | 4,607,025 | 1,649,675 | 795,465 | 541,125 |
| Previous Close | 0.0550 | 158.50 | 13.19 | 143.03 | 255.14 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4115 | 156.57 | 13.31 | 136.71 | 237.67 |
| 20-Day Raw Stochastic | 1.81% | 89.04% | 34.42% | 64.28% | 92.62% |
| 20-Day Relative Strength | 35.60% | 53.14% | 41.35% | 53.72% | 65.92% |
| Weighted Alpha | -87.09 | -11.34 | -20.97 | +43.92 | +23.85 |
| Today's Opinion | 88% Sell | 64% Sell | 100% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 88% Sell | 72% Sell | 100% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 80% Sell | 56% Sell | 80% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -89.36% since 12/13/23 | +9.04% since 04/25/24 | +1.53% since 04/25/24 | +1.50% since 04/25/24 | +9.40% since 04/25/24 |
| Low | 0.0212 on 12/20/23 | 152.63 on 04/26/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.31 on 04/30/24 |
| High | 0.4497 on 12/14/23 | 169.99 on 05/02/24 | 13.31 on 05/02/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 1-Month | |||||
| %Chg | -86.76% since 11/20/23 | +1.35% since 04/02/24 | -2.07% since 04/02/24 | +1.52% since 04/02/24 | +12.93% since 04/02/24 |
| Low | 0.0212 on 12/20/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 227.75 on 04/03/24 |
| High | 1.0600 on 11/22/23 | 169.99 on 05/02/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 260.34 on 05/02/24 |
| 3-Month | |||||
| %Chg | -92.61% since 09/20/23 | -11.54% since 02/02/24 | -7.07% since 02/02/24 | -1.35% since 02/02/24 | +20.95% since 02/02/24 |
| Low | 0.0212 on 12/20/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 1.0600 on 11/22/23 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| 6-Month | |||||
| %Chg | -96.85% since 06/20/23 | +3.93% since 11/02/23 | -4.33% since 11/02/23 | +23.32% since 11/02/23 | +13.13% since 11/02/23 |
| Low | 0.0212 on 12/20/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 2.0299 on 07/05/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 260.34 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 956 | 72,491,408 | 41,744,196 | 14,232,486 | 11,319,541 |
| Shares Outstanding, K | 23,900 | 457,359 | 3,164,837 | 99,507 | 44,366 |
| Annual Sales | 12,650,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -106,310,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 5,020,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -13,810,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 1.17 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 11/14/23 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.20 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 11/13/23 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.93 | 6.71 | 56.83 | 11.81 |